Diabetes 1. Which metrics are being captured and what is the organization trying to say? 2. Mention some possible reasons why the data captured may be questionable and not wholly reliable? 3. Outside of conventional treatment, what are some possible alternative treatment options that have worked to address your disparity? 4. Who are some stakeholders in the community you can partner with to support your response to question #3?

Diabetes

1. Which metrics are being captured and what is the organization trying to say?

2. Mention some possible reasons why the data captured may be questionable and not wholly reliable?

3. Outside of conventional treatment, what are some possible alternative treatment options that have worked to address your disparity?

4. Who are some stakeholders in the community you can partner with to support your response to question #3?